Equity Analysis

Quarterly Results

    Bharat Immunological & Biological Corporation Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524663
    INE994B01014
    -7.5352246
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    106.57
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2023Jun 2023Mar 2023
Gross Sales0.000.007.65
Other Operating Income0.000.000.00
Other Income 0.160.100.49
Total Income0.160.108.15
Total Expenditure 4.694.3111.67
PBIDT-4.52-4.21-3.53
Interest 2.091.722.06
PBDT-6.61-5.93-5.59
Depreciation0.030.030.09
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.73-1.38-1.80
Reported Profit After Tax-4.92-4.59-3.88
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-4.92-4.59-3.88
EPS (Unit Curr.)-1.14-1.06-0.90
EPS (Adj) (Unit Curr.)-1.14-1.06-0.90
Calculated EPS (Unit Curr.)-1.14-1.06-0.90
Calculated EPS (Adj) (Unit Curr.)-1.14-1.06-0.90
Calculated EPS (Ann.) (Unit Curr.)-4.56-4.25-3.59
Calculated EPS (Adj) (Ann.) (Unit Curr.)-4.56-4.25-3.59
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity43.1843.1843.18
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)17594000.0017594000.000.00
Public Shareholding (% in Equity)40.7540.750.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares25586000.0025586000.000.00
Non Encumbered - % in Total Promoters Holding100.00100.000.00
Non Encumbered - % in Total Equity59.2559.250.00
PBIDTM(%)0.000.00-46.14
PBDTM(%)0.000.00-73.07
PATM(%)0.000.00-50.72
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-1.14-1.06-0.90